Journal: Cells
Article Title: AMPK Activation Downregulates TXNIP, Rab5, and Rab7 Within Minutes, Thereby Inhibiting the Endocytosis-Mediated Entry of Human Pathogenic Viruses.
doi: 10.3390/cells14050334
Figure Lengend Snippet: Figure 7. AMPK activation downregulates Rab5, Rab7, and TXNIP rapidly. Confocal microscopy of Rab5 (magenta), Rab7 (magenta), and TXNIP (magenta) after SA (A,C), AMPK (A), ULK activator (A), and cycloheximide (B) treatment. (C) Analyses of the time-dependent downregulation of Rab5, Rab7, and TXNIP. Scale bars: 20 µm.
Article Snippet: Antibodies: Anti-PVR (CD155) Antibody, clone 4B3, ZooMab® Rabbit Monoclonal recombinant, Cells 2025, 14, 334 4 of 22 Sigma Aldrich; anti-LDL Receptor Antibody, clone 2N19, ZooMab® Rabbit Monoclonal recombinant, Sigma Aldrich (Taufkirchen, Germany); anti-Rab5A Antibody #2143, Cell Signaling; anti-Rab7 (D95F2) XP® Rabbit mAb #9367, Cell Signaling; and anti-TXNIP Antibody, clone 1K14 ZooMAb® Rabbit Monoclonal, Sigma Aldrich; anti-β-Actin Antibody, clone 6L12, ZooMAb® Rabbit Monoclonal, Sigma Aldrich; anti-SARS-CoV-2 Spike Protein (S1-NTD) Antibody #56996, Cell Signaling, anti-SARS-CoV/SARS-CoV-2 NSP8 Monoclonal Antibody (5A10), Invitrogen; and anti-LAMP1 (D4O1S) Mouse mAb #15665, Cell Signaling; anti-GRP78 Polyclonal Antibody, Invitrogen.
Techniques: Activation Assay, Confocal Microscopy